Correction to: Nature Medicine https://doi.org/10.1038/s41591-018-0053-3, published online 4 June 2018.
In the version of this article originally published, there was an error in Fig. 2n. The top line of the HR comparison chart originally was Atezo + bev vs sun. It should have been Atezo + bev vs atezo. The error has been corrected in the HTML and PDF versions of this article.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
McDermott, D.F., Huseni, M.A., Atkins, M.B. et al. Publisher Correction: Clinical activity and molecular correlates of response to atezolizumab alone or in combination with bevacizumab versus sunitinib in renal cell carcinoma. Nat Med 24, 1941 (2018). https://doi.org/10.1038/s41591-018-0235-z
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41591-018-0235-z
This article is cited by
-
Decoding the multicellular ecosystem of vena caval tumor thrombus in clear cell renal cell carcinoma by single-cell RNA sequencing
Genome Biology (2022)
-
Complementary roles of surgery and systemic treatment in clear cell renal cell carcinoma
Nature Reviews Urology (2022)
-
Tissue-resident memory T cells in the kidney
Seminars in Immunopathology (2022)
